DE60230194D1 - Therapeutische verwendung von mitgliedern der n,n-dicylcohexyl-2-hydroxy-7,7-dimethylbicycloä2.2.1ühept-1-ylmethanesulphonamide-familie - Google Patents

Therapeutische verwendung von mitgliedern der n,n-dicylcohexyl-2-hydroxy-7,7-dimethylbicycloä2.2.1ühept-1-ylmethanesulphonamide-familie

Info

Publication number
DE60230194D1
DE60230194D1 DE60230194T DE60230194T DE60230194D1 DE 60230194 D1 DE60230194 D1 DE 60230194D1 DE 60230194 T DE60230194 T DE 60230194T DE 60230194 T DE60230194 T DE 60230194T DE 60230194 D1 DE60230194 D1 DE 60230194D1
Authority
DE
Germany
Prior art keywords
family
ylmethanesulphonamide
dicylcohexyl
hydroxy
members
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60230194T
Other languages
English (en)
Inventor
Javier Llompart
Jorge Galvez
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medisyn Technologies Inc
Original Assignee
Medisyn Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medisyn Technologies Inc filed Critical Medisyn Technologies Inc
Application granted granted Critical
Publication of DE60230194D1 publication Critical patent/DE60230194D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Oncology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE60230194T 2002-09-20 2002-09-20 Therapeutische verwendung von mitgliedern der n,n-dicylcohexyl-2-hydroxy-7,7-dimethylbicycloä2.2.1ühept-1-ylmethanesulphonamide-familie Expired - Lifetime DE60230194D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/251,616 US6919376B2 (en) 2002-09-20 2002-09-20 Therapeutic agents and corresponding treatments
PCT/US2002/029951 WO2004026225A2 (en) 2002-09-20 2002-09-20 Therapeutic agents and corresponding treatments

Publications (1)

Publication Number Publication Date
DE60230194D1 true DE60230194D1 (de) 2009-01-15

Family

ID=31992784

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60230194T Expired - Lifetime DE60230194D1 (de) 2002-09-20 2002-09-20 Therapeutische verwendung von mitgliedern der n,n-dicylcohexyl-2-hydroxy-7,7-dimethylbicycloä2.2.1ühept-1-ylmethanesulphonamide-familie

Country Status (8)

Country Link
US (1) US6919376B2 (de)
EP (1) EP1560573B1 (de)
JP (1) JP4469720B2 (de)
AT (1) ATE415961T1 (de)
AU (1) AU2002357644A1 (de)
CA (1) CA2499523C (de)
DE (1) DE60230194D1 (de)
WO (1) WO2004026225A2 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040266732A1 (en) * 2002-09-20 2004-12-30 Jorge Galvez Therapeutic agents, methods, and treatments
US7652029B2 (en) * 2004-07-09 2010-01-26 Medisyn Technologies, Inc. Therapeutic compound and treatments
EP1778639B1 (de) 2004-07-15 2015-09-02 Albany Molecular Research, Inc. Aryl- und heteroarylsubstituierte tetrahydroisochinoline und verwendung damit zur wiederaufnahmeblockierung von norepinephrin, dopamin und serotonin
US9156812B2 (en) 2008-06-04 2015-10-13 Bristol-Myers Squibb Company Crystalline form of 6-[(4S)-2-methyl-4-(2-naphthyl)-1,2,3,4-tetrahydroisoquinolin-7-yl]pyridazin-3-amine
CN102638982B (zh) 2009-05-12 2015-07-08 百时美施贵宝公司 (S)-7-([1,2,4]三唑并[1,5-a]吡啶-6-基)-4-(3,4-二氯苯基)-1,2,3,4-四氢异喹啉的晶型及其用途
MX2011011901A (es) 2009-05-12 2012-01-20 Albany Molecular Res Inc Tetrahidroisoquinolinas aril, heteroaril, y heterociclo sustituidas y uso de las mismas.
KR101830447B1 (ko) * 2009-05-12 2018-02-20 알바니 몰레큘라 리써치, 인크. 7-(［1,2,4］트리아졸로［1,5-α］피리딘-6-일)-4-(3,4-디클로로페닐)-1,2,3,4-테트라하이드로이소퀴놀린 및 이의 용도
US8450350B2 (en) 2010-05-05 2013-05-28 Infinity Pharmaceuticals, Inc. Triazoles as inhibitors of fatty acid synthase
EP3159331A1 (de) 2010-05-05 2017-04-26 Infinity Pharmaceuticals, Inc. Tetrazolone als fettsäuresynthasehemmer
WO2015017798A2 (en) 2013-08-02 2015-02-05 CRIXlabs, Inc. Method and system for predicting spatial and temporal distributions of therapeutic substance carriers
JO3637B1 (ar) 2015-04-28 2020-08-27 Janssen Sciences Ireland Uc مركبات بيرازولو- وترايازولو- بيريميدين مضادة للفيروسات rsv
TW201932470A (zh) 2017-11-29 2019-08-16 愛爾蘭商健生科學愛爾蘭無限公司 具有抗ｒｓｖ活性之吡唑并嘧啶
JP7305658B2 (ja) 2018-01-31 2023-07-10 ヤンセン・サイエンシズ・アイルランド・アンリミテッド・カンパニー 抗ｒｓｖ活性を有するシクロアルキル置換ピラゾロピリミジン
AU2019260109B2 (en) 2018-04-23 2023-07-13 Janssen Sciences Ireland Unlimited Company Heteroaromatic compounds having activity against RSV

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2295616A (en) * 1994-12-01 1996-06-05 Zeneca Ltd N-Diazine-benzenesulphonamide derivatives as endothelin receptor antagonists
CA2335941C (en) 1998-06-29 2011-03-22 Barry James Maurer Treatment of hyperproliferative disorders
US6576613B1 (en) * 1998-07-24 2003-06-10 Corvas International, Inc. Title inhibitors of urokinase
US6290929B1 (en) 2000-07-28 2001-09-18 The Procter & Gamble Company Cancer treatment

Also Published As

Publication number Publication date
CA2499523C (en) 2011-04-19
JP2006503058A (ja) 2006-01-26
US6919376B2 (en) 2005-07-19
WO2004026225A2 (en) 2004-04-01
AU2002357644A1 (en) 2004-04-08
JP4469720B2 (ja) 2010-05-26
CA2499523A1 (en) 2004-04-01
AU2002357644A8 (en) 2004-04-08
WO2004026225A3 (en) 2004-07-22
ATE415961T1 (de) 2008-12-15
EP1560573B1 (de) 2008-12-03
US20040059000A1 (en) 2004-03-25
EP1560573A2 (de) 2005-08-10
EP1560573A4 (de) 2006-07-19

Similar Documents

Publication Publication Date Title
DE60230194D1 (de) Therapeutische verwendung von mitgliedern der n,n-dicylcohexyl-2-hydroxy-7,7-dimethylbicycloä2.2.1ühept-1-ylmethanesulphonamide-familie
NO20052928L (no) Nye kjemiske forbindelser
DE60223262D1 (de) Verwendung von fucanen in der behandlung von adhäsion, arthritis und psoriasis
MXPA05005107A (es) Composiciones y metodos para el diagnostico y tratamiento de tumores.
ATE496636T1 (de) Verwendung von agonisten und antagonisten von interleukin-33 (il-33)
ATE320435T1 (de) Oxazolo-, thiazolo- und selenazolo-(4,5- c)naphthyridin-4-amine und analoge davon
HK1069316A1 (en) Hmgb1 protein inhibitors and/or antagonists for the treatment of vascular diseases
DE60319158D1 (de) Pyrazoloisoquinolinenderivaten als kinase inhibitoren
NO20054371L (no) Somatostatin-dopamin kimaere analoger
AU5338301A (en) Methods and compositions for modulating alpha adrenergic receptor activity
SE0301653D0 (sv) Novel compounds
ATE256672T1 (de) 4,5-diaryl-3(2h)-furanon derivate als cyclooxygenase-2 inhibitoren
TW200505904A (en) Heterocyclyl-3-sulfonylindazoles as 5-hydroxytryptamine-6 ligands
AP2004002995A0 (en) Combination therapy for the treatment of cancer
DK0944616T3 (da) Bicykliske arylcarboxamider og deres terapeutiske anvendelse
ATE396205T1 (de) Die verwendung von peptiden von il-2 und peptid- derivaten als therapeutische wirkstoffe
PT1390371E (pt) Oxazolo- e furopirimidinas e sua utilizacao em medicamentos contra tumores
EP1589998A4 (de) Verwendung von säuger-zytokin; verwandte reagenzien
AU8497701A (en) Claudin polypeptides
SE0302304D0 (sv) Novel compounds
ATE269340T1 (de) Thiazolopyrimidine und ihre verwendung als modulatoren der chemokin-rezeptor-aktivität
ATE447426T1 (de) Elektromagnetische stimulation bei patienten mit osteoporose
ATE433458T1 (de) Modulatoren von ship-1
DE60316128D1 (de) N-sulfonylurea-apoptosis-förderer
ATE383874T1 (de) Perylenequinonen zur anwendung als sonosensitizer

Legal Events

Date Code Title Description
8328 Change in the person/name/address of the agent

Representative=s name: MAHLER, P., DIPL.-PHYS., PAT.-ANW., 22397 HAMBURG

8364 No opposition during term of opposition